Hitting target in cancer fight now easier with new nanoparticle platform, scientists say

Researchers demonstrate mesoporous silica nanoparticles (MSNP) as an optimal drug delivery platform providing the ability to change the size and surface properties of MSNP to improve the tumor biodistribution and protected delivery of doxorubicin to a cancer xenograft in a nude mice model.

Read the whole article on Science Daily

More from Science Daily